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Abstract: Fetal development is modulated by maternal nutrition during pregnancy. The dietary
intake of linoleic acid (LA), an essential dietary n-6 polyunsaturated fatty acid (PUFA), has increased.
We previously published that increased LA consumption during pregnancy does not alter offspring or
placental weight but fetal plasma fatty acid composition; the developing fetus obtains their required
PUFA from the maternal circulation. However, it is unknown if increased maternal linoleic acid
alters placental fatty acid storage, metabolism, transport, and general placental function. Female
Wistar-Kyoto rats were fed either a low LA diet (LLA; 1.44% of energy from LA) or high LA diet (HLA;
6.21% of energy from LA) for 10 weeks before pregnancy and during gestation. Rats were sacrificed at
embryonic day 20 (E20, term = 22 days) and placentae collected. The labyrinth of placentae from one
male and one female fetus from each litter were analyzed. High maternal LA consumption increased
placental total n-6 and LA concentrations, and decreased total n-3 PUFA, alpha-linolenic acid (ALA),
and docosahexaenoic acid (DHA). Fatty acid desaturase 1 (Fads1), angiopoietin-like 4 (Angptl4),
and diacylglycerol lipase beta (Daglb) mRNA were downregulated in placentae from offspring from
HLA dams. Maternal high LA downregulated the fatty acid transport protein 4 (Fatp4) and glucose
transporter 1 (Slc2a1) mRNA in placentae. IL-7 and IL-10 protein were decreased in placentae from
offspring from HLA dams. In conclusion, a high maternal LA diet alters the placental fatty acid
composition, inflammatory proteins, and expressions of nutrient transporters, which may program
deleterious outcomes in offspring.
Keywords: linoleic acid; placenta; maternal diet; fatty acids; nutrient transport
1. Introduction
Membrane phospholipids contain polyunsaturated fatty acids (PUFA), notably docosahexaenoic
acid (DHA) and arachidonic acid (AA) [1]. They act as structural and signaling components of the
membrane, and have the capacity to modulate a number of transcription factors, and downstream
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pathways [1]. In the Western diet, the most abundantly consumed omega (n)-6 PUFA is linoleic
acid (LA) [2]. Metabolism of LA can produce AA, which is a potent bioactive molecule that can be
converted into eicosanoids by oxidation [3] and involve in endocannabinoid system in the presence of
various enzymes such as fatty acid amide hydrolase (FAAH), diacylglycerol lipase (DAGL)-α, DAGL-β,
and N-acylphosphatidylethanolamines phospholipase D (NAPE-PLD) (Figure 1) [4]. Eicosanoids
generated by AA oxidation have the capacity to modulate important in physiological processes, such as
the immune response, inflammation, fever promotion, and blood pressure regulation/respiration,
whereas some are associated with disease development [3]. The n-3 PUFA, alpha-linolenic acid (ALA),
is the precursor to DHA, and DHA is highly associated with the nervous system. During development,
an increased accumulation of DHA in the infant brain is required for normal neurodevelopment.
Metabolism and degradation of LA and ALA occurs via the same enzymes, namely delta-5-desaturase
(Fads1) and delta-6-desaturase (Fads2) [5]. The fetus has insufficient Fads1 and Fads2 for the generation
of DHA and AA [6], so during pregnancy the fetus obtains PUFA from the maternal diet. In general,
PUFA are transported from the maternal to fetal circulation by proteins such as fatty acid transport
proteins (FATP) and fatty acid binding proteins (FABP) [7]. More recent research has demonstrated
that instead of simple transportation across the placental membrane, fatty acids may be incorporated
into placental lipid pools to modulate their transfer to the fetus [8].
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t lis f li l i i l i i .
t f tt i s i i l ,
rachidonic acid ( ) r ce fr
path ay. DGLA, dihomo-ga ma-linolenic acid; GLA, gamma-linolenic acid; FADS, fatty
acid desaturase; 1,2-DAG, 1,2-diacylglycerol; APE, N-arachidonoylphosphatidylethanolamine;
NAPE-PLD, NAPE-phospholipase D; FAAH, fatty acid amide hydrolase; NAT, N-acyltransferase;
DAGL, diacylglycerol lipase; MAGL, monoacylglycerol lipase. Figure adapted from [9,10] and prepared
in Biorender.
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We investigated the effects of an elevated concentration of LA during pregnancy on maternal
and fetal outcomes. An elevated maternal LA diet during pregnancy altered fatty acid composition
and circulated inflammatory proteins in our rodent model. Surprisingly, these changes did not alter
fetal weight or placental weight [11]. Of concern for fetal development, a maternal diet with elevated
LA altered maternal circulating fatty acids and leptin concentrations [11], and we have evidence that
this could lead to altered development [12]. At this time, there has been limited investigations on the
capacity of LA to alter placental function. A recent study demonstrated that a high LA diet altered the
placental expression of cholesterol packaging and transport genes in the rodent [13]. In this study, there
was an elevated content of fat, which may have contributed to the changes observed. Thus, despite
the placenta also playing an important role in development [14], at this time we do not know how
an elevated maternal LA diet during pregnancy alters fatty acid storage, metabolism and transport.
Further, as elevated LA has the capacity to affect proinflammatory protein production which can
perturb cellular function, it is important that we understand if an elevated maternal LA diet alters
placental function. Developmental programming of disease is often sex-specific, and maternal nutrition
is known to affect offspring in a sex-specific manner [15]. Recent research has also demonstrated
that the FADS genes are regulated by sex [16]. This suggests that any changes in placental function
associated with an elevated maternal LA diet may be sex-specific.
Therefore, the aim of our study was to investigate the sex-specific effects of a high maternal LA diet
before and during pregnancy on placental fatty acid storage, metabolism and transport, and general
placental function.
2. Materials and Methods
2.1. Experimental Animal Model and Diet
The animal ethics approved all analyses identified in this study (Griffith University Animal Ethics
Committee (NSC/01/17/AEC)). Eight-week-old Wistar-Kyoto (WKY) rats (n = 8 for LLA diet and n = 9
for HLA diet) were purchased from the Australian Resource Center (ARC, WA, Australia) and housed
in accordance to Australian Code of Practice for Care and Use of Animals for Scientific Purpose.
All animal experimentation described in the submitted manuscript was conducted in accord with
accepted standards of humane animal care, as outlined in the ethical guidelines.
Rats were housed in individually ventilated cages under 12 h light/12 h dark cycle at a temperature
of 20–22 ◦C and provided with food and water ad libitum throughout the experiment. Female rats
were acclimatized for a week and randomly allocated to either a low linoleic acid diet (LLA; 1.44% of
energy from LA) or a high linoleic acid diet (HLA; 6.21% of energy from LA) for 10 weeks. These diets
were matched for total carbohydrate, total fat, protein, and n-3 FA content. The composition of the diet
was detailed in our previous paper [11]. After 8 weeks of dietary exposure, vaginal impedance was
monitored daily for at least two estrous cycles using a rat vaginal impedance reader (Muromachi Kikai
Co. Ltd., Tokyo, Japan). Female rats were considered ready for mating when vaginal impedance was
greater than 4.5 × 103 Ω. Mating occurred following a WKY male rat being placed in the cage with the
female rat. Embryonic day 1 (E1) occurred the day following mating. The rats continued to be fed the
LLA or HLA diet during pregnancy until embryonic day 20 (E20; term = 22 days). At E20, pregnant
female rats were injected with an intraperitoneal (i.p.) injection of sodium pentobarbital (60 mg/kg)
form terminal anesthetization. Rats at the time when reflexes were abolished was considered to be
indicative of a humane killing. Each fetus was decapitated and had the tail removed and frozen for
genotyping of fetal sex. Four placentae from each litter were collected and placentae dissected into the
labyrinth and junctional zone, weighed and snap frozen in liquid nitrogen for storage at −80 ◦C for
RNA extraction and lipid extraction (details below). The remaining placenta were fixed whole in 4%
paraformaldehyde [17] for histological analysis.
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2.2. SRY Sex Determination
The fetal sex was determined by genotyping for each fetus [18]. Briefly, the tail was placed in DNA
extraction buffer and proteinase K at 55 ◦C overnight before ammonium acetate was added to each
sample. The DNA was precipitated out of solution using isopropanol before it was washed using 70%
ethanol and eluted in ultra-pure water. DNA concentration was assessed using the NanoDrop 1000
spectrophotometer (Thermo Fisher Scientific, Seventeen Mile Rocks, QLD, Australia) and 100 ng of
DNA was loaded per well into a PCR plate with QuantiNovaTM probe master mix (Qiagen, Chadstone,
NSW, Australia) and SRY primer probe (Rn04224592_u1; NM_012772.1; Applied Biosystems, Seventeen
Mile Rocks, QLD, Australia). TaqMan qPCR was performed using a StepOneTM PCR system (Applied
Biosystems, Seventeen Mile Rocks, QLD, Australia).
2.3. Fatty Acid Analysis in the Placental Tissue
Placentae from one male and one female per litter were analyzed for fatty acid content. Total
lipids for fatty acid analysis were extracted from the labyrinth zone of placental tissue with chloroform/
isopropanol (2:1 v/v) following the Folch method [19]. Approximately 250 mg of frozen placental
tissue was weighed and mixed with 2 mL of 0.9% saline solution. The solution was homogenized and
3 mL of isopropanol was added, vortexed, and allowed to stand for 5 min. Then, 6 mL of chloroform
was added, shaken well, and centrifuged for 10 min at 3000× g. After this, the bottom organic phase
(chloroform) was transferred into a glass scintillation vial which was evaporated to dryness under
nitrogen. This was then resuspended in a chloroform: methanol (9:1 v/v) solution and 20 µL of the
sample was spotted onto PUFA-coatTM collection paper [20], allowed to dry at room temperature,
and stored for fatty acid analysis.
The fatty acids in the labyrinth zone of the rat placenta were analyzed using gas chromatography
(GC), as previously described [20]. Briefly, samples were transesterified with 2 mL of 1% (v/v) H2SO4
in anhydrous methanol and heated for 3 h at 70 ◦C. The fatty acid methyl esters (FAME) were
extracted with heptane and injected into a GC (Hewlett-Packard 6890; Palo Alto, CA, USA) for analysis.
FAME were estimated by comparing the retention times and peak area values of unknown samples to
those of commercial lipid standards (Nu-check prep Inc., Elysian, MN, USA) using Agilent Chemstation
software. The concentration of each fatty acid examined was expressed as a percentage of total lipids.
2.4. RNA Extraction, cDNA Synthesis, and Quantitative Polymerase Chain Reaction (qPCR)
RNA from approximately 30 mg of placental labyrinth tissue was extracted from one male and one
female per litter using an RNAeasy mini kit (Qiagen, Chadstone, Australia) following manufacturer’s
guidelines. Snap frozen placental tissue (between 20 to 30 mg of weight) was homogenized using
600 µL of working RLT buffer mixed with β-mercaptoethanol. Then, the ethanol was added to the
homogenized sample and mixed immediately by pipetting. The sample was transferred to a RNeasy
spin column placed in a collection tube and the standard step by step centrifugation protocol provided
by the manufacturer was executed. RNA concentration was determined using a Nanodrop 1000
spectrophotometer (Thermo Fisher Scientific) and RNA quality was evaluated by 260/280 and 260/230
ratios. cDNA was synthesized from RNA using the iScript gDNA clear cDNA synthesis kit (Bio-Rad
Laboratories Inc., Gladesville, NSW, Australia) following manufacturer’s instructions. Quantitative
PCR, using QuantiNova SYBR® green master mix (Qiagen), was completed in line with the Minimum
Information for Publication of Quantitative Real-Time PCR Experiments (MIQE) guidelines [21].
Heat activation was run for 2 min at 95 ◦C, then 40 cycles of 95 ◦C for 5 s, and 60 ◦C for 10 s using
StepOneTM PCR systems (Applied Biosystems). Gene expression was quantified using the 2−∆∆Cq
method normalized to the geometric mean of β-actin and β-2 microglobulin as reference genes. These
reference genes were stable across the groups. All the primers used for this study were KiCqStartTM
predesigned primers from Sigma- Aldrich: β-actin (Actb; NM_031144), β-2 microglobulin (B2m;
NM_012512), fatty acid transport protein 1 (Fatp1/Slc27a1; NM_053580.2), fatty acid transport protein 4
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(Fatp4/Slc27a4; NM_001100706.1), fatty acid binding protein 3 (Fabp3; NM_024162.1), fatty acid binding
protein 5 (Fabp5; NM_145878.1), glutamic-oxaloacetic transaminase 2 (Got2; NM_013177.2), Cd36 (Fat,
NM_031561.2), lipoprotein lipase (Lpl; NM_012598.2), glucose transporter 1 (Glut1/Slc2a1; NM_138827.1),
glucose transporter 3 (Glut3/Slc2a3; NM_017102.2), glucose transporter 4 (Glut4/Slc2a4; NM_012751.1),
Slc38a1 (NM_138832.1), Slc38a2 (NM_181090.2), Slc38a4 (NM_130748.1), fatty acid desaturase 1 (Fads1;
NM_053445.2), fatty acid desaturase 2 (Fads2; NM_031344.2), vascular endothelial growth factor A
(Vegfa; NM_031836.3), hypoxia inducible factor 1 subunit alpha (Hif1a; NM_024359.1), angiopoietin-like
4 (Angptl4; NM_199115.2), fatty acid amide hydrolase (Faah; NM_001106678.1), diacylglycerol lipase
alpha (Dagla; NM_001005886.1), diacylglycerol lipase beta (Daglb; NM_001107120.1), and N-acyl
phosphatidylethanolamine phospholipase D (Napepld; NM_199381.1).
2.5. Histological Analysis
Fixed placentae were processed to paraffin and sectioned at a thickness of 7 µM using a
microtome. The first three representative midline sections, identified by the presence of the central
artery, were collected and stained with hematoxylin and eosin (H-E) [17]. The ScanScope system
(Aperio Technologies, Vista, CA, USA) was used to image the sections. General histological appearance
was assessed by a blinded observer before this same blinded observer used the Aperio ImageScope
(v12.3.0.5056) software to measure the cross-sectional areas of the junctional and labyrinth zones. Total
cross-sectional area was determined by adding the average junctional and labyrinth zone cross-sectional
areas across the three placental sections from each placenta [17].
2.6. Multiplex Assay for the Measurement of Cytokines, Chemokines and Growth Factors in Placental Tissue
Placentae from one male and one female per litter were analyzed for the concentrations of cytokines,
chemokines, and growth factors in the labyrinth zone. Briefly, protein lysate from placental tissue was
extracted using the Bio-Plex® cell lysis kit (Bio-Rad Laboratories, Inc., Gladesville, NSW, Australia).
The protein concentration was estimated using a Pierce TM BCA protein assay kit (ThermoFisher
Scientific, Seventeen Mile Rocks, QLD, Australia). The sample was diluted as directed by the
manufacturer in Bio-plex sample diluent and a step by step magnetic bead-based multiplex assay
was run following the manufacturer’s guidelines. The plate was read using the Bio-Plex 200 system
(Bio-Rad Laboratories, Inc., Gladesville, NSW, Australia). All the parameters quantified had an
intra-assay coefficient of variation less than 10%.
2.7. Statistical Analysis
All data were analyzed for normality and analyzed separately for male and female outcomes
using two-way analysis of variance (ANOVA) with diet and sex as to factors using GraphPad Prism
8.4.0 (GraphPad software, San Diego, CA, USA). One male and one female placenta was used from
each litter, with n = 8–9. All data are expressed as mean ± standard error of the mean (SEM) and
p < 0.05 was considered statistically significant.
3. Results
3.1. Effect of High Maternal LA Diet on Fatty Acid Composition in Rat Placenta
Composition of fatty acids is expressed as percentage of total lipid plasma fatty acids.
High maternal LA diet significantly increased total SFA in placental labyrinth zone (effect of diet
p < 0.0001) (Table 1). Total monounsaturated fatty acid (MUFA) was decreased in placental labyrinth
from the offspring of dams fed with HLA diet (effect of diet p < 0.0001). Total n-9 FA, total n-7 FA,
total n-3 FA, ALA (18:3n-3), and docosahexaenoic acid (DHA; 22:6n-3) were significantly decreased
in placental labyrinth from the offspring of dams fed with HLA diet compared to that fed with LLA
diet (effect of diet p < 0.0001). As expected, a high maternal LA diet significantly elevated total n-6 FA
and LA (18:2n-6) in placental labyrinth (effect of diet p < 0.0001). Surprisingly, AA, the biochemical
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metabolite of LA remained unchanged among the groups in labyrinth zone of placenta, with no sex
differences in the fatty acid composition.
Table 1. Effect of a maternal diet high in linoleic acid on fatty acid composition (% of total lipid plasma
fatty acid) in the labyrinth zone of the rat placenta.
LLA HLA p-Values
Male Female Male Female Diet Sex Interaction
Total SFA 50.98 ± 1.16 52.43 ± 1.27 57.42 ± 0.97 56.04 ± 0.51 p < 0.0001 ns ns
Total MUFA 17.56 ± 0.38 16.88 ± 0.37 8.97 ± 0.29 9.17 ± 0.22 p < 0.0001 ns ns
Total n-9 FA 14.43 ± 0.38 13.79 ± 0.37 6.71 ± 0.24 6.9 ± 0.17 p < 0.0001 ns ns
Total n-7 FA 3.13 ± 0.02 3.06 ± 0.03 2.24 ± 0.10 2.28 ± 0.05 p < 0.0001 ns ns
Total n-3 FA 2.91 ± 0.08 3.05 ± 0.20 1.92 ± 0.12 1.77 ± 0.09 p < 0.0001 ns ns
18:3n-3 (ALA) 0.3 ± 0.07 0.18 ± 0.06 0.00 ± 0.0 0.00 ± 0.0 p < 0.0001 ns ns
22:6n-3 (DHA) 2.51 ± 0.12 2.7 ± 0.13 1.92 ± 0.12 1.77 ± 0.09 p < 0.0001 ns ns
Total n-6 FA 28.35 ± 0.93 27.38 ± 0.83 31.57 ± 0.99 32.93 ± 0.51 p < 0.0001 ns ns
18:2n-6 (LA) 9.55 ± 0.40 9.17 ± 0.27 12.62 ± 0.63 13.1 ± 0.62 p < 0.0001 ns ns
20:4n-6 (AA) 16.39 ± 0.54 16.19 ± 0.37 15.91 ± 0.34 16.36 ± 0.20 ns ns ns
LLA: low linoleic acid; HLA: high linoleic acid; SFA: saturated fatty acid; MUFA: monounsaturated fatty acid; LA:
linoleic acid; AA: arachidonic acid. Placentae from one male and one female per litter were analyzed. Data expressed
as mean ± standard error of the mean (SEM) and analyzed by two-way ANOVA with diet and sex as two factors.
n = 8 (LLA) and n = 9 (HLA).
3.2. Effect of High Maternal LA Diet on Gene Expressions of Enzymes Involved in Fatty Acid Metabolism and
Transport in Labyrinth Zone of Rat Placenta
Fads1 and Fads2 are major enzymes involved in the desaturation of LA and ALA to produce
longer chain PUFAs. The mRNA expression of Fads1 was significantly downregulated in the placental
labyrinth of offspring from dams consuming a HLA diet (effect of diet p = 0.01) (Table 2). Fads2
remained unchanged among the groups. We measured the relative mRNA expression of enzymes
involved in the fatty acid metabolism in the labyrinth zone of placenta. There were no differences in the
mRNA expressions of Faah, Dagla, and Napepld (Table 2). Maternal HLA diet significantly decreased
the mRNA expression of Daglb in the labyrinth zone of placenta (effect of diet p = 0.04). Maternal
nutrition has a major impact on placental nutrient transporters; hence, we next investigated the effect
of high maternal LA diet on gene expression of fatty acid transporters in labyrinth zone of the placenta
(Table 2). The mRNA expression of Fatp4 was significantly downregulated (effect of diet p = 0.03) in
placental labyrinth of offspring from dams fed with HLA. There were no changes in the expression
of other genes related to fatty acid transport in rat placenta such as Fatp1, Fabp3, Fabp5, Got2, Cd36,
and Lpl among the groups. There were no sex-specific changes in the expression of genes associated
with fatty acid transport in the rat placenta.
Table 2. Effect of a maternal diet high in linoleic acid on relative mRNA expression of genes related to
fatty acid metabolism and transport in the labyrinth zone of the rat placenta.
LLA HLA p-Values
Male Female Male Female Diet Sex Interaction
Genes associated with fatty acid metabolism
Fads1 1.04 ± 0.11 1.07 ± 0.19 0.63 ± 0.06 0.83 ± 0.10 p = 0.010 ns ns
Fads2 1.08 ± 0.18 1.10 ± 0.22 1.08 ± 0.12 1.30 ± 0.11 ns ns ns
Faah 1.13 ± 0.20 1.14 ± 0.28 0.60 ± 0.14 0.85 ± 0.19 ns ns ns
Dagla 1.22 ± 0.37 1.09 ± 0.22 0.78 ± 0.22 0.75 ± 0.13 ns ns ns
Daglb 1.08 ± 0.17 1.06 ± 0.17 0.63 ± 0.15 0.83 ± 0.14 p = 0.04 ns ns
Napepld 1.08 ± 0.15 1.08 ± 0.21 0.96 ± 0.09 0.98 ± 0.06 ns ns ns
Nutrients 2020, 12, 2183 7 of 14
Table 2. Cont.
LLA HLA p-Values
Male Female Male Female Diet Sex Interaction
Genes associated with fatty acid transport
Fatp1 1.07 ± 0.14 1.06 ± 0.16 0.61 ± 0.13 1.03 ± 0.21 ns ns ns
Fatp4 0.86 ± 0.07 1.23 ± 0.42 0.59 ± 0.10 0.67 ± 0.09 p = 0.03 ns ns
Fabp3 1.02 ± 0.08 1.04 ± 0.13 1.32 ± 0.12 1.11 ± 0.10 ns ns ns
Fabp5 1.02 ± 0.09 1.04 ± 0.14 1.16 ± 0.07 1.07 ± 0.09 ns ns ns
Got2 1.12 ± 0.21 1.14 ± 0.24 0.96 ± 0.19 0.95 ± 0.14 ns ns ns
Cd36 1.05 ± 0.13 0.85 ± 0.05 0.86 ± 0.05 0.90 ± 0.07 ns ns ns
Lpl 1.06 ± 0.13 1.04 ± 0.15 0.85 ± 0.06 0.97 ± 0.06 ns ns ns
LLA: low linoleic acid; HLA: high linoleic acid; FADS1: fatty acid desaturase 1 (also known as delta-5 desaturase);
FADS2: fatty acid desaturase 2 (also known as delta-6-desaturase FAAH: fatty acid amide hydrolase; DAGLA:
diacylglycerol lipase alpha; DAGLB: diacylglycerol lipase beta; NAPEPLD: N-acyl phosphatidylethanolamine
phospholipase D. FATP: fatty acid transport protein; FABP: fatty acid binding protein; GOT2: glutamic-oxaloacetic
transaminase 2; CD36: cluster of differentiation 36 (also known as fatty acid translocase); LPL: lipoprotein lipase.
Placentae from one male and one female per litter were analyzed Data expressed as mean ± SEM and analyzed by
two-way ANOVA with diet and sex as two factors. n = 5–8.
3.3. Effect of High Maternal LA Diet on Placental Morphology
Despite no change in overall placental weight [11], LA may still have the capacity to negatively
affect placental morphology. H-E staining demonstrated no effect of HLA on gross morphology,
with no overt changes to specific cell types, blood space areas, or increased rate of overt abnormalities.
Furthermore, total cross-sectional area of the placentas was not affected by treatment (Figure 2).
Analysis of the placental zone cross-sectional areas (labyrinth and junctional zones) relative to the
whole placenta cross sectional area demonstrated no changes between treatments in the size of zones.
3.4. Effect of High Maternal LA Diet on the Expressions of Genes Related to Angiogenesis, Glucose Transport,
and Amino Acid Transport in Labyrinth Zone of Rat Placenta
Placental angiogenesis is critical for this organ’s function [22] and no change in weight or structure
may not be indicative of placental angiogenesis. To investigate the effect of a maternal HLA diet on
placental angiogenesis, we evaluated the mRNA expression of genes involved in angiogenesis; namely
Vegfa, Hif1a, and Angptl4 in the labyrinth zone of rat placenta (Table 3). A high maternal LA diet did
not affect the mRNA expression of Vegfa and Hif1a in the placental labyrinth, yet HLA significantly
decreased the mRNA expression of Angptl4 (effect of diet p = 0.014) in the labyrinth zone of placenta.
Because fatty acids alter glucose and amino transport [23,24], we measured the expression of genes
related to glucose and amino acid transport. The mRNA expression of glucose transporter 1 (Slc2a1)
was lower in placental labyrinth of offspring from dams consuming a HLA diet compared to offspring
from dams fed a LLA diet (effect of diet p = 0.0015). The mRNA expressions of other genes related to
glucose transport namely Slc2a3 and Slc2a4 were not different between the groups. Further, there were
no changes in the gene expression of Slc38a1, Slc38a2, and Slc38a4, which are involved in amino acid
transport and no changes were sex-specific.
Table 3. Effect of a maternal diet high in linoleic acid on relative mRNA expression of genes related to
angiogenesis, glucose transport and amino acid transport in the labyrinth zone of the rat placenta.
LLA HLA p-Values
Male Female Male Female Diet Sex Interaction
Genes related to angiogenesis
Vegfa 1.05 ± 0.13 1.13 ± 0.29 0.95 ± 0.07 0.96 ± 0.07 ns ns ns
Hif1a 1.30 ± 0.34 1.32 ± 0.31 0.92 ± 0.15 1.50 ± 0.22 ns ns ns
Angptl4 0.89 ± 0.06 1.11 ± 0.23 0.49 ± 0.11 0.71 ± 0.16 p = 0.014 ns ns
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Table 3. Cont.
LLA HLA p-Values
Male Female Male Female Diet Sex Interaction
Genes related to glucose transport
Slc2a1 1.02 ± 0.08 1.05 ± 0.17 0.61 ± 0.11 0.64 ± 0.09 p = 0.0015 ns ns
Slc2a3 1.10 ± 0.18 1.06 ± 0.16 0.80 ± 0.13 0.88 ± 0.12 ns ns ns
Slc2a4 1.11 ± 0.19 1.07 ± 0.17 0.70 ± 0.20 0.79 ± 0.18 ns ns ns
Genes related to amino acid transport
Slc38a1 1.05 ± 0.13 1.02 ± 0.10 0.81 ± 0.11 0.95 ± 0.09 ns ns ns
Slc38a2 1.10 ± 0.17 1.11 ± 0.25 0.78 ± 0.08 0.93 ± 0.12 ns ns ns
Slc38a4 1.03 ± 0.10 1.02 ± 0.11 0.88 ± 0.10 0.93 ± 0.07 ns ns ns
LLA: low linoleic acid; HLA: high linoleic acid; VEGFA: vascular endothelial growth factor A; HIF1A: hypoxia
inducible factor 1 subunit alpha; ANGPTL4: angiopoietin like 4. Placentae from one male and one female per litter
were analyzed. Data expressed as mean ± SEM and analyzed by two-way ANOVA with diet and sex as two factors.
n = 5–8.
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Figure 2. Th effect of maternal diet high in linoleic acid on gross placental morphology at embryonic
day 20. (A) Average total cro s-sectional area (mm2) in male and female placentae. (B) Percentage
labyrinth zone of total cro s-sectional area in male and female placentae. (C) Representative placental
sections of LA male placenta. (D) Representative placental sections of LA female placenta (E)
Representative placental sections of HLA male placenta. (F) R presentativ placental sections of
HLA female placenta stained with H-E at 1×magnification (scale bar = 1000 µm). n = 3–4. Data are
presented as mean ± SEM with each dot on the scatter plot symbolizing a single representative sample
taken from each litter. Data was analyzed using a two-way ANOVA with diet and sex as two factors.
LLA = low linoleic acid; HLA = high linoleic acid.
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3.5. Effect of High Maternal LA Diet on Cytokines, Chemokine, and Growth Factors in Labyrinth Zone of
Rat Placenta
Fatty acids have the potential to modulate inflammatory mediators [25] and we previously
demonstrated that hepatic maternal inflammatory mediators were altered in response to maternal
LA consumption, despite no changes in circulating maternal inflammatory mediators [11]. In this
study, we show that there were no changes in the concentrations of interleukins (IL-1β, IL-2, IL-5, IL-6),
interferon-gamma (IFN-γ), tumor necrosis factor-alpha (TNF-α), vascular endothelial growth factor
(VEGF), and monocyte chemoattractant protein 1 (MCP-1) among the groups in the placental labyrinth
zone (Table 4). Diet and sex have an interactive effect on the level of IL-1α in placental labyrinth
zone. The concentrations of IL-7 and IL-10 significantly decreased in placental labyrinth of offspring
from dams fed with HLA diet. Maternal diet and sex have interactive effect on the concentration of
regulated on activation, normal T cell express and secreted (RANTES) in placental labyrinth zone
(effect of interaction of diet and sex p = 0.008).
Table 4. Effect of a maternal diet high in linoleic acid on cytokines, chemokines, and growth factors in
the labyrinth zone of the rat placenta.
LLA HLA p-Values
Male Female Male Female Diet Sex Interaction
IL-1α (pg/mL) 10.6 ± 1.56 8.0 ± 1.22 8.0 ± 0.75 11.1 ± 1.17 ns ns p = 0.03
IL-1β (pg/mL) 45.4 ± 6.38 85.5 ± 30.01 50.3 ± 4.86 45.5 ± 1.93 ns ns ns
IL-2 (pg/mL) 987.1 ± 103.7 1411.0 ± 303.3 935.4 ± 65.2 972.5 ± 155.9 ns ns ns
IL-5 (pg/mL) 57.5 ± 7.27 57.0 ± 12.58 39.73 ± 4.40 56.4 ± 8.73 ns ns ns
IL-6 (pg/mL) 54.8 ± 7.30 38.9 ± 7.72 34.7 ± 5.34 37.8 ± 6.64 ns ns ns
IL-7 (pg/mL) 462.4 ± 53.32 380.9 ± 66.48 208.9 ± 64.7 261.4 ± 70.09 p = 0.008 ns ns
IL-10 (pg/mL) 22.49 ± 4.88 22.45 ± 5.84 11.97 ± 1.11 14.93 ± 1.62 p = 0.03 ns ns
IFN-γ (pg/mL) 39.6 ± 4.76 31.1 ± 6.76 28.5 ± 4.96 39.79 ± 5.46 ns ns ns
RANTES (pg/mL) 28.87 ± 2.11 24.5 ± 1.46 24.9 ± 1.85 33.3 ± 3.32 ns ns p = 0.008
TNF-α (pg/mL) 374.5 ± 59.84 254.8 ± 47.68 286.5 ± 12.68 327 ± 20.54 ns ns ns
VEGF (pg/mL) 10.55 ± 1.58 9.13 ± 2.70 9.2 ± 2.09 11.03 ± 2.16 ns ns ns
MCP-1 (pg/mL) 91.65 ± 8.63 77.86 ± 12.44 93.04 ± 5.53 94.36 ± 10.44 ns ns ns
LLA: low linoleic acid; HLA: high linoleic acid; IL: interleukin; IFN-γ: interferon-gamma; RANTES: regulated on
activation normal T cell expressed and secreted; TNF-α: tumor necrosis factor- alpha; VEGF: vascular endothelial
growth factor; MCP-1: Monocyte chemoattractant protein-1. Placentae from one male and one female per litter
were analyzed. Data expressed as mean ± SEM and analyzed by two-way ANOVA with diet and sex as two factors.
n = 5–8.
4. Discussion
Maternal nutrition has a major role in gestation and the long term health of the offspring through
fetal programing which are often mediated by placental adaptations [26]. In this study, we demonstrated
that a high maternal LA diet alters the placental fatty acid composition, genes responsible for the
metabolism, transport of fatty acids, genes responsible for nutrient transport, and angiogenic factors.
There is a clear difference in placental fatty acid composition in the placenta from offspring exposed
to a high maternal LA diet. Surprisingly, there are few differences in the expression of genes related
to nutrient transport and angiogenesis, and no sex-specific differences observed. Notably, this is the
first study to investigate the effect of an elevated maternal LA diet on placental fatty acid composition
and gene expression related to nutrient transport and angiogenesis, using a diet which is similar to
the Australian diet. Previous studies have investigated the effects of an elevated LA diet using a
significantly higher LA concentration. Further, a high maternal LA diet alters inflammatory mediators
in a sex-specific manner. Collectively, these may program deleterious outcomes in offspring.
Pregnancy related complications are associated with alterations of fatty acid composition in the
maternal circulation [27]. Inadequate maternal PUFA dietary intake is associated with altered placental
fatty composition and expression of FATPs [28]. A recent study reported that total fat content and
LA/ALA ratio in the maternal diet influenced the placental fatty acid composition in rat model [29].
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Similarly, we previously demonstrated that a high maternal LA diet alters maternal and fetal plasma
fatty acid composition [11]. Of note, the pattern of change in placental fatty acid composition was
similar to both the maternal and fetal circulations, with some exceptions. For example, a high maternal
LA diet increased the level of total SFA in both male and female placentae, despite the matched SFA in
the maternal diet. There were similar patterns of change in the fetal plasma, however, there was no
changes in maternal plasma level of SFA in our previous study [11]. Interestingly, in the present study,
total n-3 PUFA, ALA, and DHA were decreased in the placentae of offspring from dams fed with HLA
diet. It is important to note that this difference in fatty acid content in the placentae occurred despite
matched total n-3 PUFA in the experimental diet of both groups. This is consistent with a previous
finding that the dams exposed to high LA diets had lower placental DHA compared to those fed with
low LA diet in the rat [29]. These findings suggest altered metabolism of LA and ALA by the placenta
in response to an elevated maternal LA diet.
As n-6 FA and LA compositions were increased in the placentae of offspring from dams fed
with the HLA diet, we hypothesized that placental AA should also be increased. In our previous
study, we observed that a high maternal LA diet elevates the AA concentrations both in maternal
and fetal plasma [11]. However, in the current study (where we used the placentae from the same
animal model [11]), the proportion of AA in the placenta remained unchanged between the groups.
AA is a longer chain n-6 PUFA which is generated from LA, through FADS1 and FADS2 activity [2].
AA is the most important PUFA associated with membrane phospholipids. Upon release, AA can be
enzymatically metabolized into eicosanoids, which is associated with disease, in addition to tissue
homeostasis [3]. Previous research has demonstrated that AA is rapidly transfer from the maternal
to fetal circulation [30], however the elevated maternal and fetal concentrations, but stable placental
concentrations leads to the proposal that the placental is reducing the effect of AA on the placental
cells, but modulating the AA concentration, irrespective of its source.
LA and ALA are converted to longer chain PUFA by a consecutive series of reactions, including
desaturation in the presence of Fads1 and Fads2, and elongation and oxidation [16]. Maternal and
fetal blood fatty acid compositions are substantially influenced by the Fads1 genotype in Japanese
population [31]. Further, there is also an association between n-6 PUFA and Fads2 polymorphisms
in pregnant women [32]. Specifically, that both maternal and child FADS genotypes and haplotypes
have the capacity to influence the cord plasma PUFA concentrations and fatty acid ratios [32]. In the
present study, the mRNA expression of Fads1 was downregulated in the placentae of offspring from
dams fed with HLA diet. The decreased level of DHA, a longer chain n-3 PUFA, in the placentae
in the current study may be associated with downregulation of the expression of Fads1. Given
that LA can be metabolized to form endocannabinoids [2], we also investigated the role of high
maternal LA diet on the placental endocannabinoid system (ECS). The two main endocannabinoids,
anandamide (AEA) and 2-arachidonyl glycerol (2-AG) are derivatives of dietary LA [2]. These
endocannabinoids are synthesized and degraded in the presence of enzymes namely- FAAH, DAGL-α,
DAGL-β, and NAPE-PLD. Studies have shown that these endocannabinoids are important mediators
of placentation [33]. Recently, we have reported that high maternal LA alters the ECS in maternal and
fetal cardiac tissue [12]. The gene expression of Daglb was decreased in the placentae from offspring
from dams fed a HLA diet. However, we found no effect on the gene expressions of other enzymes
involved in ECS in placenta (Faah, Dagla, Napepld).
At this time, we do not have a clear understanding about which fatty acid transporters bind
and transport fatty acids in the placenta. In the present study, a high maternal LA diet decreased
the gene expression of Fatp4 in the placentae exposed to an elevated maternal LA diet. A previous
study reported that an increased n-6/n-3 ratio in the diet increased the porcine gene expression of Fatp1
in the longissimus dorsi muscle and subcutaneous adipose tissue [34], yet this is the first study to
report the role of a maternal high LA diet on placental gene expression of FATPs and FABPs. In a rat
model, Fatp1, Cd36, and Fabp3 mRNA were decreased in a high fat diet (HFD) exposed placentae [35].
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Of note, fat content was matched in our experimental model and there was no changes in maternal
body weight, as reported in our previous study [11].
In our previous study, we demonstrated that a high maternal LA diet altered fetal circulating
fatty acid concentration, in the absence of changes to fetal and placental weights [11]. Weight changes
may not be indicative of functional changes. The placental labyrinth zone is key for maternal/fetal
exchange and a key finding of this study is that a high maternal LA diet alters expression of nutrient
transporters in placental labyrinth at gestation day 20. Recent studies have investigated the effect of
different concentrations of LA in the maternal diet on placental weight, fatty acid composition and
expression of genes associated to cholesterol transport and packaging [13,29]. However, to the best of
our knowledge, this is the first study to investigate the effect of a high maternal LA diet on nutrient
transport and angiogenesis associated genes.
Increased plasma free fatty acid concentrations reduce glucose uptake mediated by insulin, which
may be mediated through a reduction in glucose transport [36]. We hypothesized that if a high maternal
LA diet increased the fatty acid composition within the maternal blood, this would result in altered
placental expression of genes related to glucose transport. We observed that a high maternal LA diet
decreased the expression of glucose transporter 1 (GLUT1; Slc2a1) in the placentae. A previous human
study has demonstrated that maternal obesity has the capacity to alter the expression of placental glucose
transporters Slc2a1 and circulating offspring glucose concentrations [37]. However, in our current rat
model, elevated maternal LA does not change fetal glucose concentrations [11], but as outlined here
does alter Slc2a1 expression in placenta. This does not negate a potential effect on glucose released in
response to a challenge in these offspring. Previous studies have also reported that a range of maternal
perturbations impair placental amino acid transporter expression. Maternal high fat feeding has been
shown to upregulate the expression of system A amino acid transporters in the placenta [38]. However,
a high maternal LA diet seems to have no effect on genes related to amino acid transport in placentae.
Placental angiogenesis is critical for normal fetal growth and development [39]. Diet induced
obesity has been shown to alter placental function and inhibit placental angiogenesis in a mouse
model [40]. Angiogenic factors include the vascular endothelial growth factor (VEGF), fibroblast
growth factor (FGF), angiopoietin (ANG) protein families, and hypoxia-inducible factor 1 (HIF-1),
as well as their respective receptors [39,41]. In the current study, we found no overt morphological
changes suggestive of altered vasculogenesis. Similarly, HLA had no effect on the expression of Vegfa
and Hif1a, yet the mRNA expression of Angptl4 significantly decreased in placentae of offspring from
dams fed with an HLA diet. A previous study that utilized placental derived mesenchymal stromal
cells, demonstrated that treatment of n-3 PUFA upregulate the expression of VEGF suggesting that n-3
PUFA may promote angiogenesis in the placenta [42]. In contrast, a number of studies have reported
the anti-angiogenic properties of n-3 PUFA [43,44]. Studies which have investigated n-6 PUFA have
reported stimulatory or neutral effects on angiogenesis [44,45]. In addition, cis-9, trans-11 conjugated
LA stimulates the expression of Angptl4 in placental extravillous trophoblast cells [44]. In the current
study, high maternal LA had only minor effects on angiogenic factors in the placenta with inhibition of
Angptl4 expression in the placentae the only change identified.
We have previously shown that a high maternal LA diet alters maternal hepatic inflammatory
cytokines [11]. However, few studies have specifically investigated the role of maternal PUFA
consumption on placental inflammation, with those studies that have been performed largely focused
on n-3 PUFA intake [46,47]. In the current study, a high maternal LA diet decreased the concentrations
of IL-7 and IL-10 in placentae from offspring from HLA dams. Thus, a high maternal LA diet seems
to have both pro-inflammatory and anti-inflammatory properties in the placenta, as IL-7 possesses
pro-inflammatory properties [48] and IL-10 is an anti-inflammatory cytokine [49]. Further, the sex of
the offspring determines the effect of the HLA diet on the concentration of Il-1 and RANTES in placenta.
RANTES can be downregulated by n-3 [50], yet despite both placentae from males and females born
to dams consuming high LA, the male placenta shows reduced concentration of RANTES, while the
female has elevated concentration. This suggests that expression of some inflammatory pathways may
Nutrients 2020, 12, 2183 12 of 14
be sex-specific in the placentae from offspring from HLA dams. Similar to animal studies, randomized
control trials and systematic review, it appears that LA has a dual role in inflammation [51,52].
In conclusion, the current study demonstrates the impact of a high maternal LA diet on placental
fatty acid composition and genes responsible for metabolism and transport, in addition to genes
involved in nutrient transport and angiogenesis. Further, we show that a high maternal LA diet
influenced the placental inflammatory responses. These changes suggest that the placenta exposed to
a high maternal LA diet has altered handling of fatty acids and potentially nutrient transport. As the
in-utero environment is critical for development, the present study emphasizes the importance of
exploring the role of high maternal LA diet on health in adult offspring.
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